SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000932440-16-000319
Filing Date
2016-02-12
Accepted
2016-02-12 16:06:15
Documents
1
Group Members
ALAIN SCHREIBERJAY MOORINPROQUEST ASSOCIATES IV LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13/G-A sch13g-a_4252576.htm SC 13G/A 116388
  Complete submission text file 0000932440-16-000319.txt   118113
Mailing Address 2430 VANDERBILT BEACH ROAD #108 - 190 NAPLES FL 34109
Business Address 2430 VANDERBILT BEACH ROAD #108 - 190 NAPLES FL 34109 609-919-3567
ProQuest Investments IV, L.P. (Filed by) CIK: 0001431818 (see all company filings)

IRS No.: 205935001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88256 | Film No.: 161418931
SIC: 2834 Pharmaceutical Preparations